Inhibitory Effects of an Aqueous Extract of Gynura procumbens on Human Mesangial Cell Proliferation

  • Lee, Hee-Jae (Department of Pharmacology, College of Medicine, Kangwon National University) ;
  • Lee, Byung-Cheol (Department of Internal Medicine, College of Oriental Medicine, Kyung Hee University) ;
  • Chung, Joo-Ho (Kohwang Medical Research Institute, College of Medicine, Kyung Hee University) ;
  • Wiryowidagdo, Sumali (Department of Pharmacy, Center for Natural Product Medicine Studies, University of Indonesia) ;
  • Chun, Wan-Joo (Department of Pharmacology, College of Medicine, Kangwon National University) ;
  • Kim, Sung-Soo (Department of Pharmacology, College of Medicine, Kangwon National University) ;
  • Kim, Hyun-Sook (Division of Bioscience and Biotechnology, Kangwon National University) ;
  • Choe, Myeon (Division of Bioscience and Biotechnology, Kangwon National University)
  • Published : 2007.08.31

Abstract

Gynura procumbens (Lour.) Merr. has been used in some parts of Southeast Asia as a folk medicine to treat kidney diseases, diabetes mellitus, and hyperlipidemia. The present work was undertaken to prove the mechanisms of G. procumbens in the management of glomerular diseases. We investigated the effect of an aqueous extract of G. procumbens on cell proliferation, DNA synthesis, and the expressions of $TGF-{\beta}1$, PDGF-BB, CDK1, CDK2, and CDK4 in fetal bovine serum-activated human mesangial cells (MCs). The G. procumbens extract inhibited proliferation, DNA synthesis, expressions of PDGF-BB, CDK1, and CDK2 mRNA, and expression of $TGF-{\beta}1$ protein in MCs. The inhibitory effect of G. procumbens on MC proliferation may be mediated by suppression of PDGF-BB and $TGF-{\beta}1$ expressions and the modulation of CDK1 and CDK2 expression. Therefore, G. procumbens shows promise as an adjunct therapy in preventing progressive renal diseases.

Keywords

References

  1. Border WA, Okuda S, Languino LR, Sporn MB, Ruoslahti E. Suppression of experimental glomerulonephritis by antiserum against transforming growth factor beta 1. Nature 346: 371- 374, 1990 https://doi.org/10.1038/346371a0
  2. Brooks DP, Short BG, Cyronak MJ, Contino LC, DiCristo M, Wang YX, Ruffolo RR. Comparison between carvedilol and captopril in rats with partial ablation-induced chronic renal failure. Br J Pharmacol 109: 581-586, 1993 https://doi.org/10.1111/j.1476-5381.1993.tb13610.x
  3. Floege J, Johnson RJ. Multiple roles for platelet-derived growth factor in renal disease. Miner Electrolyte Metab 21: 27-82, 1995
  4. Floege J, Ostendorf T, Janssen U, Burg M, Radeke HH, Vargeese C, Gill SC, Green LS, Janji N. Novel approach to specific growth factor inhibition in vivo: Antagonism of platelet-derived growth factor in glomerulonephritis by aptamers. Am J Pathol 154: 169 -179, 1999 https://doi.org/10.1016/S0002-9440(10)65263-7
  5. Grandaliano G, Ranieri E, Monno R, Gesualdo L, Schena F. Ramipril inhibits in vitro human mesangial cell proliferation and platelet-derived growth factor expression. Exp Nephrol 7: 229-235, 1999 https://doi.org/10.1159/000020606
  6. Iskander MN, Song Y, Coupar IM, Jiratchariyakul W. Antiinflammatory screening of the medicinal plant Gynura procumbens. Plant Foods Hum Nutr 57: 234-244, 2002
  7. Kim M, Lee HJ, Wiryowidagdo S, Kim HK. Antihypertensive effects of Gynura procumbens extract in spontaneously hypertensive rats. J Med Food 9: 587-590, 2006 https://doi.org/10.1089/jmf.2006.9.587
  8. Kurogi Y. Mesangial cell proliferation inhibitors for the treatment of proliferative glomerular disease. Med Res Rev 23: 15-31, 2003 https://doi.org/10.1002/med.10028
  9. Marshall CB, Shankland SJ. Cell cycle and glomerular disease: a minireview. Nephron Exp Nephrol 102: 39-48, 2006 https://doi.org/10.1159/000088400
  10. Perry LM, Medicinal. Plants of East and Southeast Asia: Attributed Properties and Uses. The MIT Press, England, p 94-95, 1980
  11. Praga M, Hernandez E, Montoyo C, Andres A, Ruilope LM, Rodicio JL. Long-term beneficial effects of angiotensin-converting enzyme inhibition in patients with nephrotic proteinuria. Am J Kidney Dis 20: 240-248, 1992 https://doi.org/10.1016/S0272-6386(12)80696-2
  12. Shankland SJ, Hugo C, Coats SR, Nangaku M, Pichler RH, Gordon KL, Pippin J, Roberts JM, Couser WG, Johnson RJ. Changes in cell-cycle protein expression during experimental mesangial proliferative glomerulonephritis. Kidney Int 50: 1230-1239, 1996 https://doi.org/10.1038/ki.1996.432
  13. Shankland SJ, Johnson RJ. TGF-$\beta$ in glomerular disease. Miner Electrolyte Metab 24: 168-173, 1995 https://doi.org/10.1159/000057366
  14. Terada Y, Yamada T, Nakashima O, Sasaki S, Nonoguchi H, Tomita K, Marumo F. Expression of PDGF and PDGF receptor mRNA in glomeruli in IgA nephropathy. J Am Soc Nephrol 8: 817-819, 1997
  15. Wang ZQ, Liang KH, Pahl MV, Vaziri ND. Effect of heparin on mesangial cell growth and gene expression of matrix proteins. Nephrol Dial Transplant 13: 3052-3057, 1998 https://doi.org/10.1093/ndt/13.12.3052
  16. Yokozawa T, Oura H, Hattori M, Iwano M, Dohi K. Effects of Wen-Pi-Tang and its crude drug extracts on proliferation of cultured mouse mesangial cells. Phytother Res 8: 170-173, 1994 https://doi.org/10.1002/ptr.2650080311
  17. Zhang XF, Tan BK. Effects of an ethanolic extract of Gynura procumbens on serum glucose, cholesterol and triglyceride levels in normal and streptozotocin-induced diabetic rats. Singapore Med J 41: 9-13, 2000